08/18/2025 4:13 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2025 3:36 PM | Kiniksa Pharmaceuticals International (Subject) Malley Thomas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2025 3:24 PM | Kiniksa Pharmaceuticals International (Subject) Malley Thomas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2025 3:54 PM | Kiniksa Pharmaceuticals International (Subject) Malley Thomas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2025 3:35 PM | Kiniksa Pharmaceuticals International (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2025 4:37 PM | Kiniksa Pharmaceuticals International (Subject) Paolini John F. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2025 3:30 PM | Kiniksa Pharmaceuticals International (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2025 3:30 PM | Kiniksa Pharmaceuticals International (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2025 4:23 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2025 3:16 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/29/2025 6:30 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for KNSA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kiniksa Pharmaceuticals International and its competitors with MarketBeat's FREE daily newsletter.
|
07/17/2025 6:44 PM | BlackRock, Inc. (Filed by) Kiniksa Pharmaceuticals International (Subject)
| Form SCHEDULE 13G/A | |
07/16/2025 3:30 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/14/2025 4:04 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2025 3:39 PM | Kiniksa Pharmaceuticals International (Issuer) Levy Richard S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2025 3:39 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2025 4:23 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2025 4:32 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2025 4:35 PM | Kiniksa Pharmaceuticals International (Issuer) Quart Barry D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2025 3:39 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025 4:46 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2025 3:50 PM | Kiniksa Pharmaceuticals International (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2025 3:53 PM | Kiniksa Pharmaceuticals International (Issuer) Quart Barry D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2025 3:55 PM | Kiniksa Pharmaceuticals International (Issuer) Popovits Kimberly J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2025 3:59 PM | Kiniksa Pharmaceuticals International (Issuer) McCain Tracey L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2025 4:02 PM | Kiniksa Pharmaceuticals International (Issuer) Malley Thomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2025 6:10 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/03/2025 3:30 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/28/2025 4:25 PM | Kiniksa Pharmaceuticals International (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2025 4:23 PM | Kiniksa Pharmaceuticals International (Filer)
| Form DEFA14A | |
05/22/2025 3:38 PM | Kiniksa Pharmaceuticals International (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2025 3:37 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2025 4:16 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025 3:39 PM | Kiniksa Pharmaceuticals International (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2025 4:32 PM | Kiniksa Pharmaceuticals International (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2025 4:13 PM | Kiniksa Pharmaceuticals International (Subject) Patel Sanj K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025 3:47 PM | Kiniksa Pharmaceuticals International (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 3:49 PM | Kiniksa Pharmaceuticals International (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 3:50 PM | Kiniksa Pharmaceuticals International (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 3:52 PM | Kiniksa Pharmaceuticals International (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 3:53 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
When the levee breaks (Ad) The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point.
In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks. Click here to watch the urgent broadcast and get ahead of what’s coming. |
05/05/2025 3:54 PM | Kiniksa Pharmaceuticals International (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2025 5:26 PM | Kiniksa Pharmaceuticals International (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2025 5:24 PM | Kiniksa Pharmaceuticals International (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2025 4:10 PM | Kiniksa Pharmaceuticals International (Subject) Moat Ross (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025 4:11 PM | Kiniksa Pharmaceuticals International (Subject) Ragosa Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025 3:15 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025 6:40 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2025 6:47 PM | BlackRock, Inc. (Filed by) Kiniksa Pharmaceuticals International (Subject)
| Form SCHEDULE 13G/A | |
04/23/2025 3:31 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2025 3:44 PM | Kiniksa Pharmaceuticals International (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/21/2025 4:30 PM | Kiniksa Pharmaceuticals International (Filer)
| Form DEFA14A | |
04/16/2025 3:38 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2025 3:39 PM | Kiniksa Pharmaceuticals International (Filer)
| Form PRE 14A | |
04/09/2025 3:41 PM | Kiniksa Pharmaceuticals International (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 3:42 PM | Kiniksa Pharmaceuticals International (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 3:43 PM | Kiniksa Pharmaceuticals International (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 3:44 PM | Kiniksa Pharmaceuticals International (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 3:45 PM | Kiniksa Pharmaceuticals International (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 3:45 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2025 5:57 PM | Kiniksa Pharmaceuticals International (Subject) TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
04/03/2025 4:06 PM | Kiniksa Pharmaceuticals International (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:52 PM | Kiniksa Pharmaceuticals International (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/24/2025 3:35 PM | Kiniksa Pharmaceuticals International (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:48 PM | Kiniksa Pharmaceuticals International (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:49 PM | Kiniksa Pharmaceuticals International (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:50 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:51 PM | Kiniksa Pharmaceuticals International (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:52 PM | Kiniksa Pharmaceuticals International (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:53 PM | Kiniksa Pharmaceuticals International (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 4:29 PM | Kiniksa Pharmaceuticals International (Subject) Ragosa Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025 3:37 PM | Kiniksa Pharmaceuticals International (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2025 3:38 PM | Kiniksa Pharmaceuticals International (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2025 3:47 PM | Kiniksa Pharmaceuticals International (Subject) Megna Michael R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025 3:37 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 4:13 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025 3:31 PM | Kiniksa Pharmaceuticals International (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2025 3:15 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/25/2025 6:31 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 2:45 PM | Fairmount Funds Management LLC (Filed by) Kiniksa Pharmaceuticals International (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025 4:37 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025 3:42 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 4:27 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 6:34 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 3:45 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 4:17 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024 3:34 PM | Kiniksa Pharmaceuticals International (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 6:14 PM | Kiniksa Pharmaceuticals International (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 4:25 PM | Kiniksa Pharmaceuticals International (Subject) Ragosa Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024 4:13 PM | Kiniksa Pharmaceuticals International (Subject) Megna Michael R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024 4:50 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Winning the AI War (Ad) What’s really driving the trade wars, reshoring, and sweeping executive orders? According to Porter Stansberry and Jeff Brown, it all traces back to one force: artificial intelligence.
Trump has declared AI a national priority—and is using emergency powers to funnel trillions into the companies building the digital and energy infrastructure behind America’s AI dominance. This isn’t speculation—it’s strategic deployment, already in motion. Click here to watch the urgent broadcast and discover two stocks they believe are best positioned to |
11/14/2024 3:32 PM | HHLR ADVISORS, LTD. (Filed by) Kiniksa Pharmaceuticals International (Subject)
| Form SC 13G/A | |
11/13/2024 3:30 PM | Kiniksa Pharmaceuticals International (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/06/2024 3:11 PM | Kiniksa Pharmaceuticals International (Subject) Patel Sanj K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024 3:14 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024 6:31 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/21/2024 3:11 PM | BlackRock, Inc. (Filed by) Kiniksa Pharmaceuticals International (Subject)
| Form SC 13G | |
10/17/2024 3:35 PM | Kiniksa Pharmaceuticals International (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 3:57 PM | Kiniksa Pharmaceuticals International (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024 4:29 PM | BAKER BROS. ADVISORS LP (Filed by) Kiniksa Pharmaceuticals International (Subject)
| Form SC 13D/A | |